Nanoparticle delivery systems, general approaches and their implementation in Multiple Myeloma

بواسطة de la Puente, Pilar, Azab, Abdel Kareem
الحاوية / القاعدة Eur J Haematol (2017)

3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

بواسطة de la Puente, Pilar, Azab, Abdel Kareem
الحاوية / القاعدة Future Oncol (2016)

Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models

بواسطة Bhattacharya, Somshuvra, Calar, Kristin, de la Puente, Pilar
الحاوية / القاعدة J Exp Clin Cancer Res (2020)

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

بواسطة Muz, Barbara, de la Puente, Pilar, Azab, Feda, Azab, Abdel Kareem
الحاوية / القاعدة Hypoxia (Auckl) (2015)

Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations

بواسطة Calar, Kristin, Plesselova, Simona, Bhattacharya, Somshuvra, Jorgensen, Megan, de la Puente, Pilar
الحاوية / القاعدة Cancers (Basel) (2020)

Bioengineering the Oxygen-Deprived Tumor Microenvironment Within a Three-Dimensional Platform for Studying Tumor-Immune Interactions

بواسطة Bhattacharya, Somshuvra, Calar, Kristin, Evans, Claire, Petrasko, Mark, de la Puente, Pilar
الحاوية / القاعدة Front Bioeng Biotechnol (2020)

Molecularly Targeted Therapies in Multiple Myeloma

بواسطة de la Puente, Pilar, Muz, Barbara, Azab, Feda, Luderer, Micah, Azab, Abdel Kareem
منشور في 2014

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma

بواسطة Muz, Barbara, Azab, Feda, de la Puente, Pilar, Landesman, Yosef, Azab, Abdel Kareem
الحاوية / القاعدة Transl Oncol (2017)

Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma

بواسطة de la Puente, Pilar, Azab, Feda, Muz, Barbara, Luderer, Micah, Arbiser, Jack, Azab, Abdel Kareem
الحاوية / القاعدة Leuk Lymphoma (2015)

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

بواسطة Muz, Barbara, Azab, Feda, de la Puente, Pilar, Rollins, Scott, Alvarez, Richard, Kawar, Ziad, Azab, Abdel Kareem
الحاوية / القاعدة Biomed Res Int (2015)

A CD138-Independent Strategy to Detect Minimal Residual Disease and Circulating Tumour Cells in Multiple Myeloma

بواسطة Muz, Barbara, de la Puente, Pilar, Azab, Feda, Luderer, Micah, King, Justin, Vij, Ravi, Azab, Abdel Kareem
الحاوية / القاعدة Br J Haematol (2016)

3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma

بواسطة de la Puente, Pilar, Muz, Barbara, Gilson, Rebecca C, Azab, Feda, Luderer, Micah, King, Justin, Achilefu, Samuel, Vij, Ravi, Azab, Abdel Kareem
الحاوية / القاعدة Biomaterials (2015)

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy

بواسطة Luderer, Micah John, Muz, Barbara, Alhallak, Kinan, Sun, Jennifer, Wasden, Katherine, Guenthner, Nicole, de la Puente, Pilar, Federico, Cinzia, Azab, Abdel Kareem
الحاوية / القاعدة Pharm Res (2019)

Tariquidar Sensitizes Multiple Myeloma Cells to Proteasome Inhibitors via Reduction of Hypoxia-Induced P-gp-Mediated Drug Resistance

بواسطة Muz, Barbara, Kusdono, Hubert D, Azab, Feda, de la Puente, Pilar, Federico, Cinzia, Fiala, Mark, Vij, Ravi, Salama, Noha N, Azab, Abdel Kareem
الحاوية / القاعدة Leuk Lymphoma (2017)

A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma

بواسطة Luderer, Micah John, Muz, Barbara, de la Puente, Pilar, Chavalmane, Sanmathi, Kapoor, Vaishali, Marcelo, Raymundo, Biswas, Pratim, Thotala, Dinesh, Rogers, Buck, Azab, Abdel Kareem
الحاوية / القاعدة Pharm Res (2016)

Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia

بواسطة de la Puente, Pilar, Weisberg, Ellen, Muz, Barbara, Nonami, Atsushi, Luderer, Micah, Stone, Richard M., Melo, Junia V., Griffin, James D., Azab, Abdel Kareem
الحاوية / القاعدة Leuk Res (2015)

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma

بواسطة Muz, Barbara, Buggio, Maurizio, Azab, Feda, de la Puente, Pilar, Fiala, Mark, Padval, Mahesh V., Weaver, David T., Pachter, Jonathan A., Vij, Ravi, Azab, Abdel Kareem
الحاوية / القاعدة Haematologica (2019)

Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stro...

بواسطة de la Puente, Pilar, Quan, Nancy, Hoo, Ryan Soo, Muz, Barbara, Gilson, Rebecca C., Luderer, Micah, King, Justin, Achilefu, Samuel, Salama, Noha Nabil, Vij, Ravi, Azab, Abdel Kareem
الحاوية / القاعدة Haematologica (2016)

Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid

بواسطة Hoffman, Mariah M., Zylla, Jessica S., Bhattacharya, Somshuvra, Calar, Kristin, Hartman, Timothy W., Bhardwaj, Ratan D., Miskimins, W. Keith, de la Puente, Pilar, Gnimpieba, Etienne Z., Messerli, Shanta M.
الحاوية / القاعدة Cancers (Basel) (2020)

The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma

بواسطة Burwick, Nicholas, Zhang, Michael Y, de la Puente, Pilar, Azab, Abdel Kareem, Hyun, Teresa S, Ruiz-Gutierrez, Melisa, Sanchez-Bonilla, Marilyn, Nakamura, Tomoka, Delrow, Jeffrey J, MacKay, Vivian L, Shimamura, Akiko
الحاوية / القاعدة Leuk Res (2017)